Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
about
Developmental and pathological angiogenesis in the central nervous systemOverexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-deficient miceIntraarterial administration of norcantharidin attenuates ischemic stroke damage in rodents when given at the time of reperfusion: novel uses of endovascular capabilities.Pyruvate minimizes rtPA toxicity from in vitro oxygen-glucose deprivation and reoxygenation.Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme ActivityHypoxia-ischemia or excitotoxin-induced tissue plasminogen activator- dependent gelatinase activation in mice neonate brain microvessels.Elevation of matrix metalloproteinase-9 level in cerebrospinal fluid of tick-borne encephalitis patients is associated with IgG extravassation and disease severity.A snapshot of the Ixodes scapularis degradomeThe great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disordersSerum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarctionBone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all!β-Lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microgliaKinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complexExtracellular matrix and matrix receptors in blood-brain barrier formation and stroke.Does inhibiting Sur1 complement rt-PA in cerebral ischemia?Ursolic acid reduces the metalloprotease/anti-metalloprotease imbalance in cerebral ischemia and reperfusion injury.The anti-inflammatory effects of exercise training promote atherosclerotic plaque stabilization in apolipoprotein E knockout mice with diabetic atherosclerosis.Impact of moderate blast exposures on thrombin biomarkers assessed by calibrated automated thrombography in rats.Microcystin-Leucine Arginine Causes Cytotoxic Effects in Sertoli Cells Resulting in Reproductive Dysfunction in Male Mice2-Chloroethanol Induced Upregulation of Matrix Metalloproteinase-2 in Primary Cultured Rat Astrocytes Via MAPK Signal Pathways.Mmp-9 inhibition: a therapeutic strategy in ischemic stroke.Crosstalk between cerebral endothelium and oligodendrocyte.Post-ischemic inflammation in the brain.Therapeutic effects of traditional herbal medicine on cerebral ischemia: a perspective of vascular protection.Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.Dissecting the association between migraine and stroke.Matrix Metalloproteinase-8 is a Novel Pathogenetic Factor in Focal Cerebral Ischemia.Optimal level activity of matrix metalloproteinases is critical for adult visual plasticity in the healthy and stroke-affected brain.Impaired vascular remodeling after endothelial progenitor cell transplantation in MMP9-deficient mice suffering cortical cerebral ischemia.Captopril and lisinopril only inhibit matrix metalloproteinase-2 (MMP-2) activity at millimolar concentrations.Neutrophil depletion reduces edema formation and tissue loss following traumatic brain injury in mice.Mild hypothermia reduces expression of Fas/FasL and MMP-3 after cerebral ischemia-reperfusion in rats.Interrelations between blood-brain barrier permeability and matrix metalloproteinases are differently affected by tissue plasminogen activator and hyperoxia in a rat model of embolic strokeSpatio-temporal course of macrophage-like cell accumulation after experimental embolic stroke depending on treatment with tissue plasminogen activator and its combination with hyperbaric oxygenation.Matrix metalloproteinase-9 concentration in the cerebral extracellular fluid of patients during the acute phase of aneurysmal subarachnoid hemorrhage.proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke.Anti-inflammatory effects of Chinese medicinal herbs on cerebral ischemia.Matrix metalloproteinase-9 expression in the nuclear compartment of neurons and glial cells in aging and stroke.Thrombin Enhanced Matrix Metalloproteinase-9 Expression and Migration of SK-N-SH Cells via PAR-1, c-Src, PYK2, EGFR, Erk1/2 and AP-1.Protective Effects of Dihydrocaffeic Acid, a Coffee Component Metabolite, on a Focal Cerebral Ischemia Rat Model.
P2860
Q27023250-2F05DD91-2FFA-4563-93C0-7115CD88312AQ28513365-5610F713-3966-431B-BE8E-2EA96D8DE1BFQ30840750-6F8FA2EC-7D2A-4CF5-916B-A8570D4F5248Q33554876-B8BCEB55-5DBD-47C7-97E6-18008E02A424Q34360507-99C3A5B0-4C33-4C43-BB31-FAECE20CA54AQ34937315-825A46F3-1E62-41FD-822B-0D4219CB6EB3Q35040641-2DF3FFFE-967C-441A-851E-A21710280978Q35085725-F74EEF57-BF3F-4104-B577-C50F9CA73410Q35256491-F955B042-8DA1-4018-A369-03A27C025E95Q35688512-8D66CE4C-3357-417E-826B-FDCA75085C12Q35792838-8AEE6416-1312-4479-8990-6AA7B084C0CAQ35852416-620EE8D4-4DC3-4975-9E89-CE9220F306F8Q36160999-F0EBA1E1-7E18-47F1-AD47-D631F0F891F1Q36351793-CAB8F365-54C8-4A0D-8E49-E76DC6185778Q36426567-E1677898-1110-4ADD-B20B-7D975E1A6A17Q36926500-E34020AD-6F8E-4596-A3D5-9EC390466559Q36931868-35B84CCB-BABF-4C55-AE39-B3E010DE4F99Q37272702-CF284CD3-7E2F-4AF2-A742-E55188BC29BBQ37504747-D8E66511-8ACD-4474-9D31-0D7681A9A849Q37553275-58D90565-7AD7-4CC5-98EC-AEFA4AD18FEEQ37568882-089C1F93-931E-4F6F-8D1C-6F6F01073DF3Q37620563-380B166D-7F2D-4F91-9359-F1CAADC11016Q38029598-2F9FC961-E01A-4B0E-8B75-2E9CA3921A97Q38156409-6E3AFA10-684F-46FF-A681-A3A92C293713Q38196884-208E9629-F002-4309-A86F-F4F413A79196Q38344344-C7845977-6C4D-4F18-9DFA-59EB7F71736FQ38431768-DC7562BA-C0ED-42EE-894C-C158FA15D5BDQ40272174-229C24D8-52EE-49A1-B4AC-ADE04D0F9AD6Q40685439-8C58F8CD-C290-423F-BED9-B25F21CB33CFQ41230502-F870F4C1-A961-4859-884E-4E0457FE032EQ41807851-5E014BDB-873D-4DA9-AC7C-82199E3E35A8Q41850077-6322DC39-4FAF-4F90-B6D4-2F0819382E1CQ42124550-0EA19FF6-0F18-4140-BF21-6AC12ECB5342Q42262869-23ECA4B6-D385-411C-B16D-4593542061A2Q42504071-00EF1065-8D4F-4B86-BF99-9AE1479BB4AAQ42710833-C711ECFD-F339-452D-A9B3-F0467898C4D2Q42859576-35830F7A-5EC1-4FC8-8B8D-E2CA356089DDQ46181129-2261661D-F771-44CF-8BF8-26C2CFF6E5C7Q47430650-97239036-D5E2-4A5E-8350-D759801CEB5BQ48099729-E7D505E0-7E28-4D55-BE73-91319387803E
P2860
Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
@en
Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
@nl
type
label
Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
@en
Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
@nl
prefLabel
Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
@en
Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
@nl
P2093
P2860
P1476
Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
@en
P2093
Anna Morancho
Anna Rosell
Joan Montaner
Lidia García-Bonilla
P2860
P304
P356
10.1111/J.1749-6632.2010.05734.X
P407
P577
2010-10-01T00:00:00Z